Skip to main content
Log in

Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis

  • Review
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Objective: Conflicting results regarding leptin levels in women with polycystic ovary syndrome (PCOS) have been reported. We summarize all available evidence from human participant studies to evaluate leptin levels in PCOS. Data Sources: PubMed, ClinicalTrials.gov, and Web of Science databases were searched with English-language restriction for only human beings from the inception to December 31, 2015. Search terms included PCOS (polycystic ovary syndrome or PCOS) and leptin. Methods of Study Selection: A total of 238 studies were reviewed, and a total of 19 studies, involving 991 women with PCOS and 898 controls, were eligible for our meta-analysis. Studies were eligible if provided leptin means and standard deviation in women with PCOS and healthy women controls. Results: Parameters, such as body mass index, insulin resistance (IR), and total testosterone, which may influence leptin levels were extracted. Data were collected and analyzed by RevMan 5.3 and Stata/SE14.0. The pooling analysis of all relevant studies revealed that leptin levels were significantly higher in patients with PCOS than in controls, with standardized mean difference of 1.62 (95% confidence interval: 1.01–2.23). However, the heterogeneity across studies was considerable and not eliminated in subgroup analyses. Meta-regression analysis further suggested that the heterogeneity might be relevant to variability in IR and study location. Conclusion: Elevated leptin levels are detected in women with PCOS compared with non-PCOS controls. Higher leptin levels may be correlated with IR, metabolic disorder, infertility, and even cardiovascular disease risk in PCOS, which may contribute to the etiology and development of PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod. 2012;27(1):14–24.

    Article  Google Scholar 

  2. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95(5):2038–2049.

    Article  CAS  PubMed  Google Scholar 

  3. Kyrkou G, Trakakis E, Attilakos A, et al. Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study. Arch Gynecol Obstet. 2016;293(4):915–923.

    Article  CAS  PubMed  Google Scholar 

  4. Demirel F, Bideci A, Cinaz P, et al. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome. Clin Endocrinol. 2007;67(1):129–134.

    Article  CAS  Google Scholar 

  5. Pirwany IR, Fleming R, Sattar N, Greer IA, Wallace AM. Circulating leptin concentrations and ovarian function in polycystic ovary syndrome. Eur J Endocrinol. 2001;145(3):289–294.

    Article  CAS  PubMed  Google Scholar 

  6. Reilly MP, Iqbal N, Schutta M, et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab. 2004;89(8):3872–3878.

    Article  CAS  PubMed  Google Scholar 

  7. Chapman IM, Wittert GA, Norman RJ. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol. 1997;46(2):175–181.

    Article  CAS  Google Scholar 

  8. Micic D, Macut D, Popovic V, et al. Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome. Gynecol Endocrinol. 1997;11(5):315–320.

    Article  CAS  PubMed  Google Scholar 

  9. Rizk NM, Sharif E. Leptin as well as free leptin receptor is associated with polycystic ovary syndrome in young women. Int J Endocrinol. 2015;2015:927805.

    Google Scholar 

  10. Pehlivanov B, Mitkov M. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Eur J Contracept Reprod Health Care. 2009;14(2):153–159.

    Article  CAS  PubMed  Google Scholar 

  11. Chakrabarti J. Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone. Ann Med Health Sci Res. 2013;3(2):191–196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Calvar CE, Intebi AD, Bengolea SV, Hermes R, Spinedi E. Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance [In Spanish]. Medicina (B Aires). 2003;63(6):704–710.

    CAS  Google Scholar 

  13. Bideci A, Camurdan MO, Yesilkaya E, Demirel F, Cinaz P. Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome. J Obstet Gynaecol Res. 2008;34(4):578–584.

    Article  CAS  PubMed  Google Scholar 

  14. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale(NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2015. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

    Google Scholar 

  15. Chen CI, Hsu MI, Lin SH, Chang YC, Hsu CS, Tzeng CR. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(4):264–268.

    Article  CAS  PubMed  Google Scholar 

  16. Kale-Gurbuz T, Akhan SE, Bastu E, Telci A, Iyibozkurt AC, Topuz S. Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2013;26(1):27–30.

    Article  PubMed  Google Scholar 

  17. Mancini F, Cianciosi A, Reggiani GM, Facchinetti F, Battaglia C, de Aloysio D. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study. Fertil Steril. 2009;91(6):2537–2544.

    Article  CAS  PubMed  Google Scholar 

  18. Laughlin GA, Morales AJ, Yen SS. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab. 1997;82(6):1692–1696.

    CAS  PubMed  Google Scholar 

  19. Atamer A, Demir B, Bayhan G, Atamer Y, Ilhan N, Akkus Z. Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters. J Int Med Res. 2008;36(1):96–105.

    Article  CAS  PubMed  Google Scholar 

  20. Kedikova SE, Sirakov MM, Boyadzhieva MV. Leptin levels and adipose tissue percentage in adolescents with polycystic ovary syndrome. Gynecol Endocrinol. 2013;29(4):384–387.

    Article  CAS  PubMed  Google Scholar 

  21. Pusalkar M, Meherji P, Gokral J, Savardekar L, Chinnaraj S, Maitra A. Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes. Gynecol Endocrinol. 2010;26(12):874–882.

    Article  CAS  PubMed  Google Scholar 

  22. Remsberg KE, Talbott EO, Zborowski JV, Evans RW, McHugh-Pemu K. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome. Fertil Steril. 2002;78(3):479–486.

    Article  PubMed  Google Scholar 

  23. Pourghassem Gargari B, Houjeghani S, Farzadi L, Safaeiyan A. Relationship between serum leptin, ghrelin and dietary macronutrients in women with polycystic ovary syndrome. Int J Fertil Steril. 2015;9(3):313–321.

    PubMed  PubMed Central  Google Scholar 

  24. Savastano S, Valentino R, Di Somma C, et al. Serum 25-Hydroxyvitamin D levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS. Nutr Metab (Lond). 2011;8:1743–7075.

    Article  Google Scholar 

  25. Houjeghani S, Pourghassem Gargari B, Farzadi L. Serum leptin and ghrelin levels in women with polycystic ovary syndrome: correlation with anthropometric, metabolic, and endocrine parameters. Int J Fertil Steril. 2012;6(2):117–126.

    PubMed  PubMed Central  Google Scholar 

  26. Telli MH, Yildirim M, Noyan V. Serum leptin levels in patients with polycystic ovary syndrome. Fertil Steril. 2002;77(5):932–935.

    Article  PubMed  Google Scholar 

  27. Baig M, Rehman R, Tariq S, Fatima SS. Serum leptin levels in polycystic ovary syndrome and its relationship with metabolic and hormonal profile in Pakistani females. Int J Endocrinol. 2014;2014:132908.

    Google Scholar 

  28. Yildizhan R, Ilhan GA, Yildizhan B, Kolusari A, Adali E, Bugdayci G. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome. Fertil Steril. 2011;96(1):246–250.

    Article  CAS  PubMed  Google Scholar 

  29. Sepilian VP, Crochet JR, Nagamani M. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens. Fertil Steril. 2006;85(5):1441–1447.

    Article  CAS  PubMed  Google Scholar 

  30. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.

    Article  Google Scholar 

  31. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific Publications; 1992:1377–1384.

    Google Scholar 

  32. Vidal H, Auboeuf D, De Vos P, et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest. 1996;98(2):251–255.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Morioka T, Asilmaz E, Hu J, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest. 2007;117(10):2860–2868.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Caprio M FE, Isidori AM, Averse A, Fabbri A. Leptin in reproduction. Trends Endocrinol Metab. 2001;12(12):65–72.

    Article  CAS  PubMed  Google Scholar 

  35. Dagklis T, Kouvelas D, Kallaras K, et al. Leptin increases luteinizing hormone secretion of fasting female rats. Clin Exp Obstet Gynecol. 2015;42(1):18–21.

    CAS  PubMed  Google Scholar 

  36. Karamouti M, Kollia P, Kallitsaris A, Vamvakopoulos N, Kollios G, Messinis IE. Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis. Fertil Steril. 2008;90(4 suppl):1444–1450.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xue-Lian Li MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zheng, SH., Du, DF. & Li, XL. Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis. Reprod. Sci. 24, 656–670 (2017). https://doi.org/10.1177/1933719116670265

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719116670265

Keywords

Navigation